Drug Type Radiopharmaceuticals and diagnostic agent |
Synonyms- |
Target |
Action inhibitors |
Mechanism IDO1 inhibitors(Indoleamine 2,3-dioxygenase inhibitors), IDO2 inhibitors(indoleamine 2,3-dioxygenase 2 inhibitors), TDO inhibitors(Tryptophan 2,3-dioxygenase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Discovery | - | 10 Mar 2023 |





